baber/WOPTO huggingface dataset:
Patent NZ-511084-A (NZ)
Title: An agent for treating ophthalmopathy
Inventor: NAKATA KATSUHIKO
IPC: A61K31/553
Filed: 1999-10-12
Abstract: A therapeutic agent for the treatment and/or prevention of eye disease, containing the compound represented by formula (I), wherein; R1 is a lower alkyl group, R2 is a lower alkyl group, R3 is a hydrogen or lower alkyl group, and R4 is hydrogen or a lower alkyl group.
Patent NZ-512534-A (NZ)
Title: Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
Inventor: SIKORSKI JAMES A
IPC: A61K31/235
Filed: 1999-12-17
Abstract: Described are combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. The combinations disclosed include a fibric acid derivative combined with a cholesteryl ester transfer protein (CETP) inhibitor.
Patent NZ-512625-A (NZ)
Title: A modular wheel and/or conventional wheel assembly and control system
Inventor: GRANT VERNON JOEL
IPC: B60K17/04
Filed: 1999-11-30
Abstract: A method for controlling a vehicle of the type having a plurality of ground wheels which are individually steerable and driven such that each said wheel is tangential to a circle the center of which is common for all said wheels.
Patent NZ-513958-A (NZ)
Title: Brush applicator with added helix
Inventor: THAYER JONATHAN
IPC: A46B9/02
Filed: 2000-12-21
Abstract: A mascara applicator is disclosed that comprises a conventional twisted wire core brush with a plurality of radially extending bristles regularly disposed in a first orientation. A cylindrically configured helix is twisted onto the brush around the wire core such that the brush bristles extend radially between successive loops of the helix. The helix moves at least some of the bristles to a second orientation such that one or more characteristics of the brush may be altered. Characteristics of the original brush that may be altered include mascara retention, mascara application and combing characteristics, as well as the appearance of the brush. The dimensions of the helix, the pitch of the helix and the thickness of the helix body are each pre-selected to yield the desired characteristics in the finished brush.
Patent NZ-515207-A (NZ)
Title: Heterocyclic substituted aminoazacycles useful as central nervous system agents
Inventor: SCHRIMPF MICHAEL R
IPC: A61K31/00
Filed: 2000-05-15
Abstract: A  compound  of  formula I (Z-R3) or  pharmaceutically acceptable salts where: Z  is selected from the group consisting of formulae labeled 'Z'. R1   and  R2  are  independently  selected  from  the  group consisting of hydrogen and alkyl; A  and  B are independently absent or independently selected from    the    group   consisting   of   alkenyl,    alkoxy, alkoxycarbonyl,   alkyl,   alkynyl,   carboxy,    haloalkyl, halogen, hydroxy, and hydroxyalkyl; R3 is selected from the group consisting of formulae labeled 'R3' R4 is selected from the group consisting of hydrogen, alkyl, and halogen; R5  is  selected  from  the  group consisting  of  hydrogen, alkoxy, alkyl, halogen, nitro, and -NR10R11 wherein R10  and R11 are independently selected from the group consisting  of hydrogen and lower alkyl; R6  is  selected  from  the  group consisting  of  hydrogen, alkenyl,  alkoxy, alkoxyalkoxy, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl,          alkyl,          alkylcarbonyl, alkylcarbonyloxy,  alkylthio,  alkynyl,  amino,  aminoalkyl, aminocarbonyl,  aminocarbonylalkyl, aminosulfonyl,  carboxy, carboxyalkyl,   cyano,   cyanoalkyl,  formyl,   formylalkyl, haloalkoxy,   haloalkyl,  halogen,  hydroxy,   hydroxyalkyl, mercapto,  mercaptoalkyl, nitro, 5-tetrazolyl,-NR7SO2R8,  -C (NR7)  NR8R9,-CH2C (NR7) NR8R9,-C (NOR7) R8,-C  (NCN)  R7,-C (NNR7R8) R9,-S (O) 2OR7, and-S (O) 2R7; and R7, R8,  and  R9 are  independently  selected from the  group  consisting  of hydrogen and alkyl. The  compound of formula I may be used to treat  Alzheimer's disease,    Parkinson's    disease,    attention     deficit hyperactivity  disorder,  depression,  nicotinic  withdrawal syndrome,  Tourette's  syndrome, and schizophrenia.  It  may also be used as an analgesic.
Patent NZ-517840-A (NZ)
Title: Methods and apparatus for conducting electronic transactions
Inventor: ROYER COBY
IPC: G07F7/10
Filed: 2000-08-30
Abstract: A transaction system (100) for facilitating a financial transaction requested by a user operating the user's computer (110) on a data network (102) comprises: a transaction authorizer computer (120) and a security server (130) configured to verify that an intelligent token is in the user's possession and to provide a digital credential to the user's computer if the verification is successful. The transaction authorizer is configured to authorize a transaction requested by the user based at least in part upon the digital credential provided by the user's computer via the data network.
Patent NZ-517859-A (NZ)
Title: Joint prosthesis
Inventor: KRISHNAN JEGANATH
IPC: A61F2/46
Filed: 2000-09-14
Abstract: A  prosthesis (2) for replacing a joint between  first and  second  articulating bones, the  prosthesis  comprising first  and  second  joint members (4, 6)  and  wherein:  the first  joint  member includes a first mounting member  which in  use  is mounted in an intramedullary canal of the  first bone;  the  second joint member includes a  second  mounting member  (28)  which  in use is mounted in an  intramedullary canal of the second bone; the first joint member has a  ball (30)  having a first part spherical surface and a slot  (34) extending  transversely through the ball; the  second  joint member  has  a  socket (52) having a second  part  spherical surface  which  is complementary to first spherical  surface and  a  guide  peg  (60)  which  projects  from  the  second spherical  surface and in use is located in said  slot;  and wherein  the guide peg is loose fit within the slot  thereby permitting  biaxial rotation of the second  member  relative to the first member about at least first and second axes.
Patent NZ-519172-A (NZ)
Title: Aminobenzophenones as inhibitors of IL-1beta and TNF- alpha
Inventor: OTTOSEN ERIK RYTTER
IPC: A61P31/04
Filed: 2000-11-29
Abstract: Disclosed are compounds of formula (VII), for which the substituents are defined herein. The compounds are used in the manufacture of emdicaments for the treatment of asthma, allergy, arthritis, gout, atherosclerosis, chronic inflammatory bowel disease (Crohn's disease), proliferative and inflammatory skin disorders, uveitis, septic shock, AIDS or osteoporosis.
Patent NZ-522792-A (NZ)
Title: A token delivery system
Inventor: SCOTT ANDREW EWART
IPC: G06Q30/06
Filed: 2001-06-01
Abstract: A token process that includes:- (a) Generating and storing transaction data (8) for the purchase of a product within a network database (5); (b) Sending a virtual token from a network device (6) to a handheld device (2) then generating a machine-readable representation of the token on the handheld device; (c) Reading from the handheld device the machine-readable representation with a reading device (12) to validate the token, and (d) Authorising the redemption of the product by validating the token against the transaction data (8) contained within the network database (5).
Patent NZ-523037-A (NZ)
Title: Movable transparent composite systems and a process for preparing the same
Inventor: HOPPE HANS-GEORG
IPC: B32B27/40
Filed: 2002-12-06
Abstract: The invention relates to transparent, light-stable, movable, thermoplastic composite systems comprising plastic parts and connecting hinges made of flexible, transparent, light-stable thermoplastic polyurethane.
Patent NZ-525252-A (NZ)
Title: Sulfonylguanidines for use in treating pain
Inventor: GERLACH MATTHIAS
IPC: C07D213/42
Filed: 2001-10-01
Abstract: Disclosed are sulfonylguanidine compounds and the use of sulfonylguanidine compounds of formula I or Ia, wherein: R1 is optionally substituted aryl or heteroaryl, R2 is alkyl, cycloalkyl, aryl, or heteroaryl, or ary, cycloalkylalkyl; or heteroaryl bonded via alkyl, S(O)2 or NH; or NR4R5, or SO2R6 R3 is H or CH3, or R2 and R3 together form -CH2(CH2)nCH2-, -CH2CH2OCH2CH2-, or -CH2CH2N(R8)CH2CH2-. The compounds are used for the manufacture of medicaments for the treatment of pain.
Patent NZ-526657-A (NZ)
Title: Methods of obtaining ophtalmic lenses providing the eye with reduced abberations
Inventor: PIERS PATRICIA ANN
IPC: A61B3/107
Filed: 2001-12-14
Abstract: An intraocular correction lens and a method of designing such a lens. According to the invention the lens is capable of reducing aberrations of an eye after its implantation and it is adapted to be placed between the cornea and the capsular bag of the eye. The method comprises according to the invention the steps of, (i) measuring the wavefront aberration of the uncorrected eye using a wavefront sensor; (ii) measuring the shape of at least one corneal surface in the eye using a corneal topographer; (iii) characterizing the at least one corneal surface and a lens located in the capsular bag of the eye comprising said cornea as mathematical models; (iv) calculating the resulting aberrations of said corneal surface(s) and the lens in said capsular bag by employing said mathematical models; (v) selecting an optical power of the intraocular correction lens; (vi) modeling the intraocular correction lens such that a wavefront arriving from an optical system comprising said intraocular correction lens and the mathematical models of said corneal and said lens in the capsular bag obtains reduced aberrations
Patent NZ-530366-A (NZ)
Title: Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
Inventor: JOUTSAMO TOPI
IPC: C07D239/42
Filed: 2002-07-22
Abstract: Disclosed are compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, R4 and R5 are independently selected from the list consisting of H, a straight or branched alkyl or alkoxy group with 1 to 4 carbon atoms, or a halogen; X is H, a straight or branched alkyl group with 1 to 4 carbon atoms, phenyl or -OH; Z is H, acetyl, -CH2-Ph-O-CF3 or CH2-Ph-CF3; Y is a ring structure linked to formula (I) directly or with an alkyl chain having one or two carbon atoms. Further disclosed is the use of said compounds for the manufacture of a pharmaceutical preparation useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor in a mammal. The pharmaceutical preparation containing this compound may be useful in treating a coronary heart disease, acute myocardial infarction, unstable angina pectoris, Prinzmetal's variant form of angina pectoris, other forms of chronic angina pectoris, essential hypertension, restenosis after coronary angioplasty or a vascular disease such as: vasoconstriction subsequent to subachnoid haemorrhage, hypoxic brain damage subsequent to subarachnoid haemorrhage, migraine, Raynaud's disease, cold intolerance, pre-eclampsia, male erectile dysfunction or obesity.
Patent NZ-531173-A (NZ)
Title: Particle cassette, method and kit therefor
Inventor: SMITH EDWARD ROBERT
IPC: A61M5/24
Filed: 2002-07-25
Abstract: A particle cassette for a needleless syringe is provided, the manufacture of which avoids the potentially detrimental use of heat when affixing a final membrane to the cassette or otherwise sealing the cassette after a filling procedure has been carried out. The particle cassette is assembled using first and second cassette parts that are attachable together so as to create a chamber for the confinement of particles between two membranes. A third cassette part may be used to provide for a locking attachment of the first and second parts. A kit of parts for use in the manufacture of a particle cassette is also provided, as is a method of assembling a particle cassette. In certain cassette embodiments, one or both of the first and second cassette parts can be annular, tapered and/or have detents or recesses to provide for a snap fit.
Patent NZ-532575-A (NZ)
Title: Information archiving software
Inventor: MOORE ALAN
IPC: G06F7/24
Filed: 2002-10-31
Abstract: Information archiving software is for a computer system where the computer system has access to at least one primary information storage system, and an archiving information storage system. The information archiving software is adapted to execute the steps of: (i) determining at least one attribute of collections of information stored within a primary information storage system, (ii) testing the attribute or attributes of the collections of stored information within the primary information storage system against at least one pre- defined rule, (iii) transferring information collections with associated attributes which pass the at least one test from the primary information storage system to the archiving storage system and (iv) storing reference stub information within the location of the primary information storage system from which the information collection was removed, the reference stub information indicating the location within the archiving information storage system where the transferred information is stored, wherein the information archiving software is implemented as a stand-alone computer application or process independent of any file serving functionality. (62) Divided out of 515148
Patent NZ-536646-A (NZ)
Title: A system and method for creation of load units
Inventor: DICKNER ALLAN
IPC: B65B35/52
Filed: 2003-04-24
Abstract: The present invention concerns a system and a method for load unit (4) creation. The system includes two or more stations (8-10), in which the load units (4) are formed. In a first station (8), one or more packages (1) are collected and placed to form the load unit (4). In later stations loading ledges (2) are added to the load units (4), and straps (7) and/or stretch wrapping is wound around the load units (4).
Patent NZ-537448-A (NZ)
Title: Stable solid medicinal composition for oral administration
Inventor: SUGIHARA AKIO
IPC: A61P1/00
Filed: 2004-01-30
Abstract: Disclosed is a stable oral solid drug composition of ramosetron or a pharmaceutically acceptable salt thereof, which comprises one or more selected from the group consisting of the following (i) to (vi); (i) an aliphatic carboxylic acid selected from the group consisting of maleic acid, malonic acid, succinic acid, and fumaric acid or an ester thereof, (ii) a hydroxycarboxylic acid selected from the group consisting of tartaric acid, malic acid, and citric acid, or an ester thereof, (iii) an acidic amino acid selected from the group consisting of aspartic acid and glutamic acid, (iv) an enolic acid selected from the group consisting of ascorbic acid and erythorbic acid, (v) an aromatic carboxyl compound selected from the group consisting of phthalic acid and propyl gallate, or an ester thereof, (vi) a carboxyl group-containing high-molecular substance selected from the group consisting of carboxymethyl cellulose and alginic acid.
Patent NZ-538288-A (NZ)
Title: Treatment of melanoma by reduction in clusterin levels
Inventor: JANSEN BURKHARD
IPC: A61K38/00
Filed: 2003-08-21
Abstract: Disclosed is the use of a clusterin inhibitor in the manufacture of a medicament for treating melanoma, wherein the clusterin inhibitor is not a siRNA molecule.
Patent NZ-545632-A (NZ)
Title: 2-Alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia
Inventor: LEE ANDREW GEORGE
IPC: A61K31/59
Filed: 2004-09-06
Abstract: Disclosed is a use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 in the manufacture of a medicament for treating frailty, muscle damage or sarcopenia.
Patent NZ-550748-A (NZ)
Title: Cable connection device
Inventor: OGDEN BRUCE JAMES
Filed: 2006-10-25
Abstract: A cable interconnection clamp includes first and second clamping portions 2 and 4 with opposed clamping faces 3, 5 which are brought together as the screw 14 is tightened. A detent between the first and second clamp faces holds the clamp portions apart until the compressive force applied by the screw displaces the detent to permit the closing of the clamps portions together.
Patent NZ-551281-A (NZ)
Title: Mixtures of anthranilamide invertebrate pest control agents
Inventor: ANNAN ISAAC BILLY
IPC: A01N43/56
Filed: 2005-07-22
Abstract: Disclosed is a mixture comprising 3-bromo-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (Formula 1), or an N-oxide or salt thereof, and at least one invertebrate pest control agent selected from neonicotinoids, cholineseterase inhibitors, sodium channel modulators, chitin synthesis inhibitors, ecdysone agonists and antagonists, lipid biosynthesis inhibitors, macrocyclic lactones, GABA-regulated chloride channel blockers, juvenile hormone mimics, ryanodine receptor ligands other than the compound of Formula 1, octopamine receptor ligands, mitochondrial electron transport inhibitors, nereistoxin analogs, pyridalyl, flonicamid, pymetrozine, dieldrin, metaflumizone, biological agents, and salts thereof.
Patent NZ-551515-A (NZ)
Title: Gooseneck semi-trailer for transporting containers with crane part displaceable along chassis
Inventor: HAMMAR BENGT-OLOF
Filed: 2006-11-23
Abstract: The disclosure relates to a semi-trailer (1) for transporting containers which is connected to a tractor unit, comprising a gooseneck chassis and a container lifting device with at least one crane part (3) displaceable along the chassis (2). The chassis comprises frame portions which are vertically displaced relative to each other, where the available vertical space for driving the displaceable crane part (3) is limited particularly in the transition between said frame portions. The displacement of the crane part (3) on one frame portion of the chassis (2) takes place by means of a linearly operating, longitudinally variable elongate actuator, which both in the retracted and in the extended state is positioned substantially within the height limits of the chassis and has a substantially constant angle to the chassis (2). A vertically articulated link arm is at one end connected to a driving part of the actuator and at the other end articulated to said displaceable crane part (3).
Patent NZ-553266-A (NZ)
Title: 15beta-substituted steroids having selective estrogenic activity
Inventor: LOOZEN HUBERT JAN JOZEF
Filed: 2005-09-05
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds have selective estrogenic activity and are useful in the treatment of estrogen receptor-related diseases or physiological conditions e.g. hormone treatment, osteoporosis and contraception.
Patent NZ-553506-A (NZ)
Title: Fused tricyclic derivatives for the treatment of psychotic disorders
Inventor: BENTLEY JOHATHAN
IPC: A61P25/00
Filed: 2005-08-29
Abstract: Disclosed is a compound of formula (I), or a salt thereof, wherein --- is a single or double bond, ring Q is a 5-membered heteroaromatic or heterocyclic ring containing at least one nitrogen and optionally 1 to 3 additional hetero atoms each selected from oxygen, nitrogen, and sulfur, B is CR7R8 or CR7 as appropriate, Y is CR7, CR7R8, O, or S(O)t, X is CR1, N, or C, A is an optionally substituted bicyclic ring selected from a list, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating diseases or disorders mediated by modulation of the 5-HT1 receptor, or the serotonin re-uptake receptor, including premature ejaculation.
Patent NZ-560942-A (NZ)
Title: Monoclonal and polyclonal antibodies to equine albumin and hemoglobin and apparatus and methods using the antibodies in the identification and localization of ulcers and other digestive tract bleeding in equines
Inventor: PELLEGRINI FRANKLIN L
Filed: 2007-08-27
Abstract: A rapid test kit for the detection and localization of ulcers or digestive tract bleeding in equines, comprising: a first test strip for a rapid immunoassay or peroxidase reaction to detect the presence of a gastric ulcer or bleeding and or a colonic ulcer or bleeding in an equine; wherein said first test strip detects the presence of equine haemoglobin which is indicative of the presence of a gastric ulcer or bleeding and/or a colonic ulcer or bleeding in an equine; and a second test strip for a rapid immunoassay to detect the presence of a colonic ulcer or bleeding in an equine; wherein said second test strip detects the presence of equine albumin which is indicative of the presence of a colonic ulcer or bleeding in an equine. Also disclosed is a method of making said rapid test kit.
Patent NZ-563489-A (NZ)
Title: Vessel with bow attached low drag submerged asymmetric displacement lifting body
Inventor: LOUI STEVEN
IPC: B63B1/00
Filed: 2004-04-30
Abstract: A watercraft includes a hull with a fore and aft longitudinal axis, a bow on the axis, and three dimensional low drag submerged lifting body secured to the bow. The lifting body has a fore and aft axis and an outer surface of a shape conforming in plan view to a parabolic curve centred on the fore and aft axis to define a leading edge of the lifting body in plan, and in longitudinal cross section views parallel to the fore and aft axis to symmetrical and graduated generally parabolic foil curves having vertices lying of the first parabolic curve, with the thickness of the parabolic foil shaped longitudinal cross section shapes decreasing away from the fore and aft axis to the edge of the lifting body.
Patent NZ-565428-A (NZ)
Title: Wheel suspension arm
Inventor: KOSCHINAT HUBERT B
IPC: B60G9/00
Filed: 2006-08-09
Abstract: The invention relates to a wheel suspension arm, especially a trailing arm for a vehicle. Said wheel suspension arm comprises a link opening (12) for swivelably securing the wheel suspension arm to a vehicle frame and an axle opening (11) for securing an axle element to the wheel suspension arm. On its peripheral edge (11a), said axle opening (11) comprises at least one discontinuation, for example a slot (13). The invention also relates to a method for producing the wheel suspension arm and to wheel suspension comprising said wheel suspension arm.
Patent NZ-565798-A (NZ)
Title: Wave protection structure, method for producing a toe element for a wave protection structure, and method for producing a wave protection structur
Inventor: VAN DEN BERGE ARNOUD
IPC: E02B3/12
Filed: 2006-07-13
Abstract: Wave protection structure for a slope, where the slope merges into a bed at the location of a toe, is disclosed. The wave protection structure comprises a plurality of wave protection elements of the interlocking type and a plurality of toe elements. The wave protection elements are each provided with a plurality of projections, where the projections extend in a plurality of planes to form a three-dimensional structure for the dissipation of wave energy. Also, the wave protection elements may engage in spaces between the projections of one or more adjacent wave protection elements in such a manner that the freedom of movement of the wave protection elements is limited in three dimensions. The wave protection elements on the slope are provided in a substantially regular imaginary grid, with a horizontal grid spacing between the centres of gravity of the wave protection elements. The toe elements extend in a longitudinal direction of the toe in order to counteract displacement of the wave protection elements from the slope to the bed, and are of a shape which deviates from the shape of the wave protection elements. The centres of gravity of the toe elements, in the longitudinal direction of the toe, are provided at substantially the same horizontal grid spacing from one another as the wave protection elements.